← Leaderboards
Jon David Levine
University Of California, San Francisco
$42,152,746
Attributed
$42,152,746
Total exposure
23
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$53,335,263 · 25
By mechanism
R01$38,485,428 · 17
P01$14,284,329 · 7
P50$565,506 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Andrew Vaughan$5,293,800
Others in their field
Top investigators on “Hyperalgesia”
- Kalpna Gupta · University Of Minnesota Twin Cities$16,616,117
- Boris Tabakoff · University Of Colorado Denver$14,836,168
- Bradley K Taylor · University Of Pittsburgh At Pittsburgh$11,999,293
- Frank Porreca · University Of Arizona$11,843,869
- Donald A Simone · Hillhurst Biopharmaceuticals, Inc.$11,524,756
- Gerald F Gebhart · University Of Iowa$11,211,662
Research focus
HyperalgesiaPainNociceptorsStressAcuteChronicInflammatorySyndromeChronic PainPlaySecond Messenger SystemsAnalgesicsBaseMediatingPathway InteractionsDesignSecond MessengerInflammationNovel StrategiesFunctional DisorderReceptorInvestigationAffectSignal Pathway
Grant awards (128)
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress$648,263
R01 · FY2023 · CA · contact PI
Hyaluronan signaling to nociceptors in inflammatory pain$623,537
R01 · FY2023 · AR · contact PI
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress$649,128
R01 · FY2022 · CA · contact PI
Hyaluronan signaling to nociceptors in inflammatory pain$617,300
R01 · FY2022 · AR · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$616,880
R01 · FY2022 · AR · contact PI
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress$675,669
R01 · FY2021 · CA · contact PI
Hyaluronan signaling to nociceptors in inflammatory pain$604,830
R01 · FY2021 · AR · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$604,415
R01 · FY2021 · AR · contact PI
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress$664,091
R01 · FY2020 · CA · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$621,503
R01 · FY2020 · AR · contact PI
Hyaluronan signaling to nociceptors in inflammatory pain$587,384
R01 · FY2020 · AR · contact PI
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress$661,511
R01 · FY2019 · CA · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$618,449
R01 · FY2019 · AR · contact PI
Hyaluronan signaling to nociceptors in inflammatory pain$584,804
R01 · FY2019 · AR · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$616,841
R01 · FY2018 · AR · contact PI
Nociceptor mechanisms in the transition from acute to chronic pain$602,544
R01 · FY2018 · NS · contact PI
Vascular Pain Mechanisms$440,990
R01 · FY2018 · NS · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$659,794
R01 · FY2017 · AR · contact PI
Nociceptor mechanisms in the transition from acute to chronic pain$602,409
R01 · FY2017 · NS · contact PI
Vascular Pain Mechanisms$448,454
R01 · FY2017 · NS · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$659,794
R01 · FY2016 · AR · contact PI
Nociceptor mechanisms in the transition from acute to chronic pain$602,243
R01 · FY2016 · NS · contact PI
Vascular Pain Mechanisms$455,768
R01 · FY2016 · NS · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$659,101
R01 · FY2015 · AR · contact PI
Nociceptor mechanisms in the transition from acute to chronic pain$603,900
R01 · FY2015 · NS · contact PI
Vascular Pain Mechanisms$465,526
R01 · FY2015 · NS · contact PI
Nociceptor mechanisms in the transition from acute to chronic pain$92,311
R01 · FY2015 · NS · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$656,325
R01 · FY2014 · AR · contact PI
Nociceptor mechanisms in the transition from acute to chronic pain$599,061
R01 · FY2014 · NS · contact PI
Vascular Pain Mechanisms$471,571
R01 · FY2014 · NS · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$100,000
R01 · FY2014 · AR · contact PI
Acute-to-Chronic Transition in Ergonomic Muscle Pain: Nociceptor Mechanisms$652,856
R01 · FY2013 · AR · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$313,864
R01 · FY2013 · AR · contact PI
Mechanisms of Interactions of Alcohol Abuse HIV Neuropathogenesis$330,795
R01 · FY2012 · AA · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$330,383
R01 · FY2012 · AR · contact PI
Receptors and Second Messengers for Pain and Analgesia$1,009,371
P01 · FY2011 · NS · contact PI
Modeling Kappa Opioid Analgesic Mechanisms in Chronic Orofacial Pain Disorders$548,565
R01 · FY2011 · DE · contact PI
Mechanisms of Interactions of Alcohol Abuse HIV Neuropathogenesis$330,795
R01 · FY2011 · AA · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$330,383
R01 · FY2011 · AR · contact PI
Mechanisms and Risk Factors in Musculoskeletal Pain$309,385
R01 · FY2011 · AR · contact PI
PKC-e Mechanisms in Acute and Chronic Pain$276,311
P01 · FY2011 · NS · contact PI
Receptors and Second Messengers for Pain and Analgesia$1,019,566
P01 · FY2010 · NS · contact PI
Modeling Kappa Opioid Analgesic Mechanisms in Chronic Orofacial Pain Disorders$556,620
R01 · FY2010 · DE · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$344,149
R01 · FY2010 · AR · contact PI
Mechanisms of Interactions of Alcohol Abuse HIV Neuropathogenesis$344,149
R01 · FY2010 · AA · contact PI
Mechanisms and Risk Factors in Musculoskeletal Pain$322,276
R01 · FY2010 · AR · contact PI
Sex dimorphism in neuroendocrine control of inflammation$288,186
R01 · FY2010 · AR · contact PI
PKC-e Mechanisms in Acute and Chronic Pain$279,104
P01 · FY2010 · NS · contact PI
Receptors and Second Messengers for Pain and Analgesia$989,873
P01 · FY2009 · NS · contact PI
Modeling Kappa Opioid Analgesic Mechanisms in Chronic Orofacial Pain Disorders$548,400
R01 · FY2009 · DE · contact PI
Mechanisms of Interactions of Alcohol Abuse HIV Neuropathogenesis$347,625
R01 · FY2009 · AA · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$347,625
R01 · FY2009 · AR · contact PI
Integrin family of proteins in acute and chronic pain$337,544
R01 · FY2009 · NS · contact PI
Mechanisms and Risk Factors in Musculoskeletal Pain$325,532
R01 · FY2009 · AR · contact PI
Sex dimorphism in neuroendocrine control of inflammation$291,098
R01 · FY2009 · AR · contact PI
PKC-e Mechanisms in Acute and Chronic Pain$277,543
P01 · FY2009 · NS · contact PI
Receptors and Second Messengers for Pain and Analgesia$24,000
P01 · FY2009 · NS · contact PI
Receptors and Second Messengers for Pain and Analgesia$967,229
P01 · FY2008 · NS · contact PI
Modeling Kappa Opioid Analgesic Mechanisms in Chronic Orofacial Pain Disorders$534,965
R01 · FY2008 · DE · contact PI
Mechanisms of Interactions of Alcohol Abuse HIV Neuropathogenesis$347,625
R01 · FY2008 · AA · contact PI
Integrin family of proteins in acute and chronic pain$337,180
R01 · FY2008 · NS · contact PI
Mechanisms and Risk Factors in Musculoskeletal Pain$325,532
R01 · FY2008 · AR · contact PI
Sex dimorphism in neuroendocrine control of inflammation$290,706
R01 · FY2008 · AR · contact PI
Ethanol-induced symptomatic peripheral neuropathy$280,267
R01 · FY2008 · AA · contact PI
PKC-e Mechanisms in Acute and Chronic Pain$263,227
P01 · FY2008 · NS · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$216,795
R01 · FY2008 · AR · contact PI
Receptors and Second Messengers for Pain and Analgesia$993,738
P01 · FY2007 · NS · contact PI
Modeling Kappa Opioid Analgesic Mechanisms in Chronic Orofacial Pain Disorders$548,956
R01 · FY2007 · DE · contact PI
Integrin family of proteins in acute and chronic pain$336,087
R01 · FY2007 · NS · contact PI
Mechanisms and Risk Factors in Musculoskeletal Pain$331,279
R01 · FY2007 · AR · contact PI
Sex dimorphism in neuroendocrine control of inflammation$295,678
R01 · FY2007 · AR · contact PI
PKC-e Mechanisms in Acute and Chronic Pain$286,981
P01 · FY2007 · NS · contact PI
Ethanol-induced symptomatic peripheral neuropathy$280,267
R01 · FY2007 · AA · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$221,220
R01 · FY2007 · AR · contact PI
Administration$59,969
P01 · FY2007 · NS · contact PI
Gender and Sex Hormones and Opioid Analgesia$549,174
R01 · FY2006 · NR · contact PI
Integrin family of proteins in acute and chronic pain$344,626
R01 · FY2006 · NS · contact PI
Sex dimorphism in neuroendocrine control of inflammation$303,270
R01 · FY2006 · AR · contact PI
Ethanol-induced symptomatic peripheral neuropathy$288,638
R01 · FY2006 · AA · contact PI
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$227,827
R01 · FY2006 · AR · contact PI
Trigeminal Pain, Mechanisms and Control$1,002,842
P01 · FY2005 · DE
Gender and Sex Hormones and Opioid Analgesia$546,330
R01 · FY2005 · NR
Ethanol-induced symptomatic peripheral neuropathy$299,756
R01 · FY2005 · AA
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$233,310
R01 · FY2005 · AR
Mechanisms of Pain Caused by Disruption of Microtubles$168,176
P01 · FY2005 · DE
Core--Histology$111,697
P01 · FY2005 · DE
Trigeminal Pain, Mechanisms and Control$975,698
P01 · FY2004 · DE
Gender and Sex Hormones and Opioid Analgesia$535,166
R01 · FY2004 · NR
Ethanol-induced symptomatic peripheral neuropathy$303,000
R01 · FY2004 · AA
Role of Subdiaphragmatic Vagus in Fibromyalgia Syndrome$259,888
R01 · FY2004 · AR
Antiviral Nucleoside-Induced Neuropathic Pain Mechanisms$258,125
R01 · FY2004 · NS
NEURAL/ENDOCRINE MEDIATED AUTOREGULATION OF INFLAMMATION$242,638
R01 · FY2004 · AR
Mechanisms of Pain Caused by Disruption of Microtubles$161,956
P01 · FY2004 · DE
Core--Histology$118,545
P01 · FY2004 · DE
Trigeminal Pain, Mechanisms and Control$1,111,665
P01 · FY2003 · DE
Gender and Sex Hormones and Opioid Analgesia$522,889
R01 · FY2003 · NR
Antiviral Nucleoside-Induced Neuropathic Pain Mechanisms$258,125
R01 · FY2003 · NS
NEURAL/ENDOCRINE MEDIATED AUTOREGULATION OF INFLAMMATION$242,638
R01 · FY2003 · AR
Mechanisms of Pain Caused by Disruption of Microtubles$159,422
P01 · FY2003 · DE
Core--Histology$105,735
P01 · FY2003 · DE
Trigeminal Pain, Mechanisms and Control$70,902
P01 · FY2003 · DE
Trigeminal Pain, Mechanisms and Control$35,295
P01 · FY2003 · DE
Trigeminal Pain, Mechanisms and Control$1,077,231
P01 · FY2002 · DE
Gender and Sex Hormones and Opioid Analgesia$506,807
R01 · FY2002 · NR
SEX DIFFERENCES IN INFLAMMATORY PAIN$282,750
R01 · FY2002 · NR
Antiviral Nucleoside-Induced Neuropathic Pain Mechanisms$258,125
R01 · FY2002 · NS
NEURAL/ENDOCRINE MEDIATED AUTOREGULATION OF INFLAMMATION$242,638
R01 · FY2002 · AR
Painful Diabetic Neuropathy$188,502
P50 · FY2002 · NS
Mechanisms of Pain Caused by Disruption of Microtubles$151,174
P01 · FY2002 · DE
Core--Histology$100,117
P01 · FY2002 · DE
Trigeminal Pain, Mechanisms and Control$1,047,881
P01 · FY2001 · DE
GENDER AND SEX HORMONES AND OPIOID ANALGESIA$425,636
R01 · FY2001 · NR
SEX DIFFERENCES IN INFLAMMATORY PAIN$275,149
R01 · FY2001 · NR
NEURAL MECHANISMS OF PAIN AND HYPERALGESIA$271,937
R01 · FY2001 · NS
Antiviral Nucleoside-Induced Neuropathic Pain Mechanisms$258,125
R01 · FY2001 · NS
NEURAL/ENDOCRINE MEDIATED AUTOREGULATION OF INFLAMMATION$242,638
R01 · FY2001 · AR
Painful Diabetic Neuropathy$188,502
P50 · FY2001 · NS
Mechanisms of Pain Caused by Disruption of Microtubles$151,174
P01 · FY2001 · DE
Core--Histology$100,117
P01 · FY2001 · DE
TRIGEMINAL PAIN--MECHANISMS AND CONTROL$857,226
P01 · FY2000 · DE
GENDER AND SEX HORMONES AND OPIOID ANALGESIA$420,589
R01 · FY2000 · NR
SEX DIFFERENCES IN INFLAMMATORY PAIN$267,769
R01 · FY2000 · NR
NEURAL MECHANISMS OF PAIN AND HYPERALGESIA$264,044
R01 · FY2000 · NS
NEURAL/ENDOCRINE MEDIATED AUTOREGULATION OF INFLAMMATION$242,638
R01 · FY2000 · AR
Painful Diabetic Neuropathy$188,502
P50 · FY2000 · NS
CORE--HISTOLOGY$165,282
P01 · FY2000 · DE
TOLERANCE AND DEPENDENCE MECHANISMS INVOLVED IN ANTINOCICEPTION$165,282
P01 · FY2000 · DE
NEURAL MECHANISMS OF PAIN AND HYPERALGESIA$50,000
R01 · FY2000 · NS